J&J Unit Slams Diabetes Drug Blood Disorder Claims

By Dan Packel (March 8, 2016, 5:07 PM EST) -- A Johnson & Johnson unit has hit back at allegations that its Type 2 diabetes drug Invokana caused a man to contract the potentially life-threatening condition diabetic ketoacidosis, telling a Pennsylvania court that his drug design defect claims were federally preempted....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!